Long-term survival in a child with severe encephalopathy, multiple respiratory chain deficiency and GFM1 mutations

Sara Brito1, Kyle Thompson2, Jaume Campistol3

  • 1Serviço de Pediatria, Centro Hospitalar de Leiria, Hospital de Santo André Leiria, Portugal ; Neuromuscular Unit, Neuropaediatrics Department, Hospital Sant Joan de Déu Barcelona, Spain.

Frontiers in Genetics
|April 9, 2015
PubMed

Insights

Novel mutations in the GFM1 gene cause mitochondrial translation defects, leading to severe early-onset disease. This case highlights a GFM1 mutation patient with a stable course, surviving beyond childhood.

Area of Science:

  • Genetics
  • Molecular Biology
  • Biochemistry

Background:

  • Mitochondrial diseases often stem from OXPHOS system deficiencies.
  • Nuclear gene defects impacting mitochondrial translation cause severe phenotypes.

Observation:

  • An infant presented with severe encephalopathy, seizures, and lactic acidemia.
  • Brain imaging showed corpus callosum thinning and white matter alterations.
  • Genetic analysis revealed novel GFM1 mutations.

Findings:

  • The GFM1 gene encodes mitochondrial translation elongation factor G1 (mtEFG1).
  • Mutations resulted in combined OXPHOS deficiencies.
  • This patient exhibited a stable clinical course, unlike previously reported fatal cases.

Implications:

  • GFM1 gene defects increase susceptibility to neurological and hepatic dysfunction.
  • This case expands the known GFM1-related disease spectrum and prognosis.
  • Understanding these mutations is crucial for diagnosing and managing mitochondrial disorders.
Abstract

Related Concept Videos

Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.2K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.0K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
681
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.6K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.6K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
637